Did Pfizer Commit Huge Fraud in Its COVID Vaccine Research?

< Please Share This

by Dr. Joseph Mercola

STORY AT-A-GLANCE

  • In November 2021, Brook Jackson, a whistleblower who worked on Pfizer’s Phase 3 COVID jab trial in the fall of 2020, warned she’d seen evidence of fraud in the trial
  • With the release of Pfizer trial data — which they tried to withhold for 75 years — additional problems suggestive of fraud and data manipulation are coming to light
  • Trial site 1231, located in Argentina, somehow managed to recruit 10% of the total trial participants, 4,501 in all, and they did so in just three weeks, and without a contract research organization — a feat that has many questioning whether fraud was committed
  • The lead investigator for trial site 1231 is Dr. Fernando Polack, who also happens to be a consultant for the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (RBPAC), a current adjunct professor at Vanderbilt University in Tennessee, an investigator for Fundación Infant, funded by the Bill & Melinda Gates foundation, and the first author of Pfizer’s paper, “Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,” published at the end of December 2021
  • Site 1231 held a second enrollment session, given the designation of “site 4444.” The 4444 trial site data raise another red flag. It supposedly enrolled 1,275 patients in a single week, from September 22 through 27, 2020 — the last week that recruitment could take place to meet the data cutoff for the FDA meeting in December 2020. Was “site 4444” fabricating data to create the appearance that the jab was having an effect?

In November 2021, Brook Jackson, a whistleblower who worked on Pfizer’s Phase 3 COVID jab trial in the fall of 2020, warned she’d seen evidence of fraud in the trial.

Data were falsified, patients were unblinded, the company hired poorly trained people to administer the injections, and follow-up on reported side effects lagged way behind. The revelation was published in The British Medical Journal. In his November 2, 2021, report, investigative journalist Paul Thacker wrote:1

“Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal COVID-19 vaccine trial raise questions about data integrity and regulatory oversight …

[F]or researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety … Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding.”

Jackson, a former regional director of Ventavia Research Group, a research organization charged with testing Pfizer’s COVID jab at several sites in Texas, repeatedly “informed her superiors of poor laboratory management, patient safety concerns and data integrity issues,” Thacker wrote.

When her concerns were ignored, she finally called the U.S. Food and Drug Administration and filed a complaint via email. Jackson was fired later that day after just two weeks on the job. According to her separation letter, management decided she was “not a good fit” for the company after all.

She provided The BMJ with “dozens of internal company documents, photos, audio recordings and emails” proving her concerns were valid, and according to Jackson, this was the first time she’d ever been fired in her 20-year career as a clinical research coordinator.

articles.mercola.com < continue reading & to watch videos